MedPath
FDA Approval

CARVEDILOL

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
RedPharm Drug, Inc.
DUNS: 828374897
Effective Date
February 2, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Carvedilol(12.5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RedPharm Drug, Inc.

RedPharm Drug, Inc.

828374897

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CARVEDILOL

Product Details

NDC Product Code
67296-1497
Application Number
ANDA078165
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 2, 2023
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
HYDROXYETHYL CELLULOSE, UNSPECIFIEDInactive
Code: T4V6TWG28DClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 800Inactive
Code: UH6KR4953DClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 0K47UL67F2Class: ACTIBQuantity: 12.5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath
CARVEDILOL - FDA Approval | MedPath